These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6485432)

  • 1. [Lidocaine elimination and dose adjustment in acute heart infarct and heart insufficiency].
    Kettner W; Banditt P; Walther H
    Z Gesamte Inn Med; 1984 Jul; 39(14):335-42. PubMed ID: 6485432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative studies on dose adjustment of intraoperative lidocaine therapy in heart failure patients].
    Biscoping J; Kling D; von Bormann B; Hehrlein F; Hempelmann G
    Anasth Intensivther Notfallmed; 1985 Jun; 20(3):136-8. PubMed ID: 4037261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention, clinical aspects and therapy of the side-effects of lidocaine].
    Kettner W; Lenz M; Kettner E; Banditt P; Walther H
    Z Gesamte Inn Med; 1984 Oct; 39(20):501-5. PubMed ID: 6516492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma level of lidocaine following intraoperative bolus injection and infusion in heart failure].
    Biscoping J; von Bormann B; Boldt J; Kling D; Hempelmann G
    Anasth Intensivther Notfallmed; 1984 Oct; 19(5):250-2. PubMed ID: 6335002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic characteristics of lidocaine in patients with circulatory failure].
    Kukes VG; Gneushev ET; Utlinskaia MG; Burian EF; Starodubtsev AK
    Farmakol Toksikol; 1981; 44(4):447-50. PubMed ID: 7286204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of lidocaine after intramuscular injection in patients with acute myocardial infarction (author's transl)].
    Oltmanns D; Siegers CP
    Z Kardiol; 1979 Mar; 68(3):131-6. PubMed ID: 442753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum concentration measurements for the monitoring of anti-arrhythmic therapy with lidocaine].
    Follath F; Heierli B; Ganzinger U; Wenk M
    Schweiz Med Wochenschr; 1980 Jun; 110(26):1007-10. PubMed ID: 6158756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of the use of lidocaine on patients with acute myocardial infarct].
    Beloev I; Tomov I; Dzhonov A; Orbetsov M; Stankusheva G
    Vutr Boles; 1983; 22(3):88-95. PubMed ID: 6649590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Slower lidocaine elimination and dose adjustment in patients with heart failure].
    Follath F; Ritz R; Vozeh S; Wenk M
    Schweiz Med Wochenschr; 1982 May; 112(22):789-91. PubMed ID: 6808662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of lidocaine after intramuscular injection and subsequent infusion in patients with acute myocardial infarction.
    Oltmanns D; Lübben C; Pentz R; Siegers CP
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):582-4. PubMed ID: 7152740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimum dosage of lidocaine.
    Laurikainen E; Arstila M; Pekkarinen A; Kanto J
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):16-9. PubMed ID: 3988388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lidocaine pharmacokinetics when administered intramuscularly].
    Piotrovskiĭ VK; Smirnova EB; Riabokon' OS; Metelitsa VI
    Farmakol Toksikol; 1980; 43(4):411-6. PubMed ID: 7439378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of propranolol, phenytoin and lidocaine in hypercholesterolemic rabbits].
    Vinçon G; Ploux D; Pehourcq F; Albin H
    J Pharmacol; 1983; 14(1):47-55. PubMed ID: 6834851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lidocaine prophylaxis for fatal ventricular arrhythmias after acute myocardial infarction.
    Pharand C; Kluger J; O'Rangers E; Ujhelyi M; Fisher J; Chow M
    Clin Pharmacol Ther; 1995 Apr; 57(4):471-8. PubMed ID: 7712677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pharmacokinetics and the concentration-and-effect relationship of prazosin in patients at the beginning of the subacute period of myocardial infarct complicated by the development of heart failure].
    Ol'binskaia LI; Petrosian IuR; Gofman AM
    Farmakol Toksikol; 1989; 52(5):68-72. PubMed ID: 2599083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations.
    Sawyer DR; Ludden TM; Crawford MH
    Arch Intern Med; 1981 Jan; 141(1):43-5. PubMed ID: 7447583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent lidocaine disposition in patients with acute myocardial infarction.
    Cusson J; Nattel S; Matthews C; Talajic M; Lawand S
    Clin Pharmacol Ther; 1985 Apr; 37(4):381-6. PubMed ID: 3978999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.